Jonathan Chung to Receptor, Fibroblast Growth Factor, Type 2
This is a "connection" page, showing publications Jonathan Chung has written about Receptor, Fibroblast Growth Factor, Type 2.
Connection Strength
0.183
-
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer. Clin Cancer Res. 2020 11 15; 26(22):5974-5989.
Score: 0.183